Opko Health (OPK) EBITDA: 2010-2025
Historic EBITDA for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $48.1 million.
- Opko Health's EBITDA rose 238.04% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$112.2 million, marking a year-over-year increase of 40.29%. This contributed to the annual value of -$152.1 million for FY2024, which is 3.16% up from last year.
- Opko Health's EBITDA amounted to $48.1 million in Q3 2025, which was up 180.12% from -$60.0 million recorded in Q2 2025.
- Over the past 5 years, Opko Health's EBITDA peaked at $48.1 million during Q3 2025, and registered a low of -$87.8 million during Q3 2022.
- In the last 3 years, Opko Health's EBITDA had a median value of -$60.0 million in 2025 and averaged -$35.3 million.
- In the last 5 years, Opko Health's EBITDA plummeted by 977.86% in 2024 and then soared by 238.04% in 2025.
- Quarterly analysis of 5 years shows Opko Health's EBITDA stood at -$63.1 million in 2021, then grew by 12.39% to -$55.3 million in 2022, then declined by 24.93% to -$69.0 million in 2023, then skyrocketed by 52.00% to -$33.1 million in 2024, then spiked by 238.04% to $48.1 million in 2025.
- Its last three reported values are $48.1 million in Q3 2025, -$60.0 million for Q2 2025, and -$67.2 million during Q1 2025.